Showing results (101-110 of 427) with videos related to

Sort By:
Pageof 43
Leukemia & Lymphoma|November 23, 2019
The role of cladribine in acute myeloid leukemia: an old drug up to new tricksMatteo Molica, Massimo Breccia, Saveria Capria, et al.
Leukemia & Lymphoma|September 10, 2023
Validation of imatinib therapy failure score (IMTF) in chronic phase chronic myeloid leukemia in real life practiceClaudia Ielo, Emilia Scalzulli, Ida Carmosino, et al.
Acta Haematologica|March 23, 2004
Acute myeloid leukemia secondary to a myelodysplastic syndrome with t(3;3) (q21;q26) in an HIV patient treated with chemotherapy and highly active antiretroviral therapyMassimo Breccia, Giuseppe Gentile, Pietro Martino, et al.
British Journal of Haematology|February 14, 2002
Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remissionGiovanni F Torelli, Anna Guarini, Gabriella Palmieri, et al.
Leukemia|May 6, 2020
Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitorsAndreas Hochhaus, Massimo Breccia, Giuseppe Saglio, et al.
European Journal of Haematology|September 7, 2004
Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosisMassimo Breccia, Gianna Maria D'Elia, Gabriella Girelli, et al.
Leukemia Research|December 9, 2008
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual diseaseMassimo Breccia, Laura Cannella, Caterina Stefanizzi, et al.
Leukemia Research|August 22, 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulationsFlorian Nolte, Emanuele Angelucci, Massimo Breccia, et al.
Expert Opinion on Pharmacotherapy|March 15, 2024
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitorsAlessandro Costa, Emilia Scalzulli, Ida Carmosino, et al.
Leukemia & Lymphoma|November 25, 2024
Clinical and biological advances of critical complications in acute myeloid leukemiaAlessandro Costa, Emilia Scalzulli, Ida Carmosino, et al.
Pageof 43